Progranulin deficiency in Iba-1


Journal

Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974

Informations de publication

Date de publication:
25 Jul 2021
Historique:
received: 27 01 2021
accepted: 23 06 2021
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 8 2 2022
Statut: epublish

Résumé

Age-related macular degeneration (AMD) is the principal cause of permanent blindness among elderly individuals worldwide. Chronic inflammation in the subretinal space is associated with a progression of exudative AMD. Progranulin (PGRN) is a growth factor secreted from myeloid cells and plays an important role in controlling the lysosomal function. A deficiency in PGRN leads to inflammation of the neurons in the central nervous system. The purpose of this study was to investigate the role played by PGRN in the size of the choroidal neovascularization (CNV) in laser-induced CNV mice. CNVs were induced in C57BL/6J mice by laser photocoagulation of the retina. The expression of PGRN and the accumulation of Iba-1 Iba-1 These findings indicate that PGRN deficiency in Iba-1

Sections du résumé

BACKGROUND BACKGROUND
Age-related macular degeneration (AMD) is the principal cause of permanent blindness among elderly individuals worldwide. Chronic inflammation in the subretinal space is associated with a progression of exudative AMD. Progranulin (PGRN) is a growth factor secreted from myeloid cells and plays an important role in controlling the lysosomal function. A deficiency in PGRN leads to inflammation of the neurons in the central nervous system. The purpose of this study was to investigate the role played by PGRN in the size of the choroidal neovascularization (CNV) in laser-induced CNV mice.
METHODS METHODS
CNVs were induced in C57BL/6J mice by laser photocoagulation of the retina. The expression of PGRN and the accumulation of Iba-1
RESULTS RESULTS
Iba-1
CONCLUSIONS CONCLUSIONS
These findings indicate that PGRN deficiency in Iba-1

Identifiants

pubmed: 34304733
doi: 10.1186/s12974-021-02203-1
pii: 10.1186/s12974-021-02203-1
pmc: PMC8310601
doi:

Substances chimiques

Aif1 protein, mouse 0
Calcium-Binding Proteins 0
Cytokines 0
Microfilament Proteins 0
Progranulins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

164

Informations de copyright

© 2021. The Author(s).

Références

Am J Pathol. 2011 Jan;178(1):284-95
pubmed: 21224065
Sci Transl Med. 2017 Apr 12;9(385):
pubmed: 28404863
J Clin Invest. 2019 Jun 24;129(8):3032-3034
pubmed: 31232702
Sci Rep. 2017 May 10;7(1):1679
pubmed: 28490764
Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3586-92
pubmed: 12882811
Nat Rev Immunol. 2013 Jun;13(6):438-51
pubmed: 23702979
Cell Mol Life Sci. 2016 May;73(9):1765-86
pubmed: 26852158
Nat Struct Biol. 1996 Sep;3(9):747-52
pubmed: 8784346
Neuron. 2010 Nov 18;68(4):654-67
pubmed: 21092856
Arch Ophthalmol. 2005 Jul;123(7):914-21
pubmed: 16009831
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):4997-5006
pubmed: 28979997
Cell. 2016 May 5;165(4):921-35
pubmed: 27114033
Oncogene. 2017 Feb 2;36(5):714-722
pubmed: 27345409
Nat Med. 2003 Feb;9(2):225-9
pubmed: 12524533
Am J Pathol. 2011 May;178(5):2416-23
pubmed: 21514452
EMBO J. 2021 Mar 15;40(6):e105123
pubmed: 33555074
Nat Protoc. 2013 Nov;8(11):2197-211
pubmed: 24136346
Hum Mol Genet. 2017 Mar 1;26(5):969-988
pubmed: 28073925
Cells. 2019 Mar 11;8(3):
pubmed: 30862089
Behav Brain Res. 2007 Dec 28;185(2):110-8
pubmed: 17764761
Mol Vis. 2016 Feb 03;22:116-28
pubmed: 26900328
J Clin Invest. 2007 Apr;117(4):902-9
pubmed: 17364026
Diabetes. 2009 Mar;58(3):627-36
pubmed: 19056610
J Clin Invest. 2007 Oct;117(10):2920-8
pubmed: 17909628
Mediators Inflamm. 2015;2015:740357
pubmed: 26339140
Neuroscience. 2013 Oct 10;250:8-19
pubmed: 23830905
J Cell Mol Med. 2016 Mar;20(3):506-17
pubmed: 26757107
Bioessays. 2009 Nov;31(11):1245-54
pubmed: 19795409
Mol Vis. 2018 Jul 30;24:536-545
pubmed: 30090016
J Neuroinflammation. 2017 Feb 23;14(1):42
pubmed: 28231837
Dig Dis Sci. 2014 Aug;59(8):1733-42
pubmed: 24591016
Nat Rev Neurosci. 2017 Jun;18(6):325-333
pubmed: 28435163
Biomed Res Int. 2016;2016:6958752
pubmed: 27747237
Hum Immunol. 2014 Jan;75(1):10-4
pubmed: 24135266
Korean J Intern Med. 2014 Jan;29(1):1-11
pubmed: 24574826
Sci Rep. 2015 Apr 30;5:9898
pubmed: 25927172
Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1799-1800
pubmed: 30132279
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):19-24
pubmed: 26603154
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Trends Neurosci. 2020 Jun;43(6):433-449
pubmed: 32459994
Lab Invest. 2017 Jan;97(1):4-13
pubmed: 27869795
Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4596-4605
pubmed: 31675076
Nature. 2006 Aug 24;442(7105):916-9
pubmed: 16862116
Epilepsia. 2014 Jun;55(6):e56-9
pubmed: 24779634
J Neurosci. 2015 Sep 9;35(36):12488-501
pubmed: 26354916
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5934-43
pubmed: 19578022
Brain Res. 2014 Nov 7;1588:168-74
pubmed: 25234724
Exp Eye Res. 2018 Jan;166:56-69
pubmed: 29042140
Atherosclerosis. 2009 Sep;206(1):102-8
pubmed: 19321167
J Vet Med Sci. 2018 Mar 2;80(2):346-353
pubmed: 29249750

Auteurs

Kei Takahashi (K)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.

Shinsuke Nakamura (S)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.

Wataru Otsu (W)

Department of Biomedical Research Laboratory, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.

Masamitsu Shimazawa (M)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.
Department of Biomedical Research Laboratory, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.

Hideaki Hara (H)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan. hidehara@gifu-pu.ac.jp.
Department of Biomedical Research Laboratory, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan. hidehara@gifu-pu.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH